Literature DB >> 6346111

Changes in blood pressure, urinary kallikrein, and urinary prostaglandin E2 in rats with streptozotocin-induced diabetes.

M Hayashi, S Senba, I Saito, W Kitajima, T Saruta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346111     DOI: 10.1007/bf00508345

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  19 in total

1.  A non-chromatographic non-extraction radioimmunoassay for serum aldosterone.

Authors:  T Ogihara; K Iinuma; K Nishi; Y Arakawa; A Takagi
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

2.  Renin, angiotensin, and norepinephrine in alloxan diabetes.

Authors:  A R Christlieb
Journal:  Diabetes       Date:  1974-12       Impact factor: 9.461

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.

Authors:  K Abe; M Yasujima; N Irokawa; M Seino; S Chiba; Y Sakurai; M Sato; Y Imai; K Saito; T Ito; T Haruyama; Y Otsuka; K Yoshinaga
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

5.  Early arteriolar disturbances following streptozotocin-induced diabetes mellitus in adult mice.

Authors:  H G Bohlen; B A Niggl
Journal:  Microvasc Res       Date:  1980-07       Impact factor: 3.514

6.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

7.  New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.

Authors:  T Morita; H Kato; S Iwanaga; K Takada; T Kimura
Journal:  J Biochem       Date:  1977-11       Impact factor: 3.387

8.  Streptozotocin-induced diabetes in the spontaneously hypertensive rat.

Authors:  P Somani; H P Singh; R K Saini; A Rabinovitch
Journal:  Metabolism       Date:  1979-11       Impact factor: 8.694

9.  Influence of streptozotocin-induced diabetes on blood pressure and on renin formation and release.

Authors:  L Kohler; N Boillat; P Lüthi; J Atkinson; L Peters-Haefeli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

10.  Determinants of glomerular filtration and plasma flow in experimental diabetic rats.

Authors:  L D Michels; M Davidman; W F Keane
Journal:  J Lab Clin Med       Date:  1981-12
View more
  5 in total

1.  Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation.

Authors:  A A Jaffa; D H Miller; G S Bailey; J Chao; H S Margolius; R K Mayfield
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

3.  Reduced GABAergic inhibition of kidney-related PVN neurons in streptozotocin-treated type 1 diabetic mouse.

Authors:  Yanyan Jiang; Hong Gao; Amanda M Krantz; Andrei V Derbenev; Andrea Zsombok
Journal:  J Neurophysiol       Date:  2013-08-21       Impact factor: 2.714

4.  Relevance of plasma, glandular and urinary kallikrein in renal hypertrophy in streptozotocin-diabetic rats.

Authors:  M I Sulaiman; S F Al-Fayz
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

Review 5.  Involvement of (pro)renin receptor in the glomerular filtration barrier.

Authors:  Atsuhiro Ichihara; Mariyo Sakoda; Asako Kurauchi-Mito; Yuki Kaneshiro; Hiroshi Itoh
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.